1. Home
  2. CAPR vs BLZE Comparison

CAPR vs BLZE Comparison

Compare CAPR & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPR
  • BLZE
  • Stock Information
  • Founded
  • CAPR 2005
  • BLZE 2007
  • Country
  • CAPR United States
  • BLZE United States
  • Employees
  • CAPR N/A
  • BLZE N/A
  • Industry
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • CAPR Health Care
  • BLZE Technology
  • Exchange
  • CAPR Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • CAPR 324.6M
  • BLZE 300.7M
  • IPO Year
  • CAPR N/A
  • BLZE 2021
  • Fundamental
  • Price
  • CAPR $6.28
  • BLZE $8.35
  • Analyst Decision
  • CAPR Strong Buy
  • BLZE Strong Buy
  • Analyst Count
  • CAPR 8
  • BLZE 7
  • Target Price
  • CAPR $24.75
  • BLZE $10.21
  • AVG Volume (30 Days)
  • CAPR 1.4M
  • BLZE 755.2K
  • Earning Date
  • CAPR 08-11-2025
  • BLZE 08-07-2025
  • Dividend Yield
  • CAPR N/A
  • BLZE N/A
  • EPS Growth
  • CAPR N/A
  • BLZE N/A
  • EPS
  • CAPR N/A
  • BLZE N/A
  • Revenue
  • CAPR $13,392,150.00
  • BLZE $137,286,000.00
  • Revenue This Year
  • CAPR N/A
  • BLZE $16.78
  • Revenue Next Year
  • CAPR $6,061.53
  • BLZE $13.98
  • P/E Ratio
  • CAPR N/A
  • BLZE N/A
  • Revenue Growth
  • CAPR N/A
  • BLZE 19.08
  • 52 Week Low
  • CAPR $3.98
  • BLZE $3.94
  • 52 Week High
  • CAPR $23.40
  • BLZE $8.65
  • Technical
  • Relative Strength Index (RSI)
  • CAPR 36.33
  • BLZE 75.27
  • Support Level
  • CAPR $6.17
  • BLZE $7.99
  • Resistance Level
  • CAPR $7.30
  • BLZE $8.65
  • Average True Range (ATR)
  • CAPR 0.43
  • BLZE 0.38
  • MACD
  • CAPR -0.11
  • BLZE 0.04
  • Stochastic Oscillator
  • CAPR 4.53
  • BLZE 77.08

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: